Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (S) Phenylethylene Glycol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109628504A details a biphasic microbial resolution method. This technology enhances purity and yield for pharmaceutical intermediates while offering supply chain cost advantages.
Patent CN101302543A reveals a microbial method for high-purity (S)-phenylethylene glycol. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN104726355B reveals yeast spore technology for high-purity chiral intermediates with enhanced stability and supply chain reliability for global pharmaceutical manufacturing partners.
Patent CN104561136A enables high-yield chiral aryl ortho-diol production. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN101368168B enables high-purity chiral alcohol production via enzyme coupling. This method offers substantial cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN104774778A details recombinant Candida parapsilosis for high-purity (S)-phenylethylene glycol. Offers cost reduction and supply chain reliability for pharmaceutical intermediates.
Novel enzymatic coupling method for (S)-phenylethylene glycol production. Reduces coenzyme costs and improves supply chain reliability for pharmaceutical intermediates globally.
Patent CN104561136B enables high-yield chemo-enzymatic synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.